Medicare provider payments and utilization data for Arkansas (AR)
Arkansas received $8.8B in total Medicare provider payments across 10 years of data.
The top specialty by spending is Hematology-Oncology, accounting for $77.0M in payments across 68 providers.
In 2023, 10.2K providers were actively billing Medicare in Arkansas.
AI-generated analysis based on Medicare payment data.
Providers in this state flagged by the ML v2 fraud detection model
| Year | Payments | Services | Providers | YoY Change |
|---|---|---|---|---|
| 2014 | $763.3M | 25.4M | 7.6K | — |
| 2015 | $809.5M | 28.1M | 8.0K | +6.0% |
| 2016 | $838.7M | 29.5M | 8.3K | +3.6% |
| 2017 | $865.3M | 30.0M | 8.8K | +3.2% |
| 2018 | $899.9M | 31.6M | 9.1K | +4.0% |
| 2019 | $992.5M | 32.9M | 9.4K | +10.3% |
| 2020 | $885.0M | 31.0M | 9.5K | -10.8% |
| 2021 | $941.9M | 31.8M | 9.8K | +6.4% |
| 2022 | $917.9M | 31.9M | 10.0K | -2.5% |
| 2023 | $905.3M | 30.0M | 10.2K | -1.4% |
| Code | Description | Payments | Services | Providers |
|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | $81.0M | 1.2M | 4.3K |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | $39.9M | 789.0K | 4.2K |
| J9271 | Injection, pembrolizumab, 1 mg | $35.9M | 835.9K | 40 |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | $21.4M | 374.9K | 1.5K |
| A0427 | Ambulance service, advanced life support, emergency transport, level 1 (als 1 - emergency) | $19.9M | 53.8K | 55 |
| 66984 | Removal of cataract with insertion of prosthetic lens | $18.8M | 43.3K | 208 |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | $17.4M | 202.8K | 959 |
| J0178 | Injection, aflibercept, 1 mg | $16.1M | 23.5K | 30 |
| J0897 | Injection, denosumab, 1 mg | $14.6M | 800.7K | 163 |
| A0425 | Ground mileage, per statute mile | $14.4M | 1.9M | 59 |
| 97110 | Therapy procedure using exercise to develop strength, endurance, range of motion, and flexibility, each 15 minutes | $13.6M | 815.4K | 660 |
| J9299 | Injection, nivolumab, 1 mg | $13.0M | 549.6K | 30 |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | $12.4M | 100.1K | 1.2K |
| 99285 | Emergency department visit with high level of medical decision making | $11.6M | 90.9K | 543 |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | $11.3M | 113.1K | 2.1K |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | $10.7M | 116.4K | 1.1K |
| J2777 | Injection, faricimab-svoa, 0.1 mg | $9.6M | 331.3K | 19 |
| A0431 | Ambulance service, conventional air services, transport, one way (rotary wing) | $9.1M | 2.1K | 11 |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | $8.6M | 261.9K | 178 |
| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | $8.5M | 254.3K | 16 |
| Specialty | Payments | Providers | Avg per Provider |
|---|---|---|---|
| Hematology-Oncology | $77.0M | 68 | $1.1M |
| Family Practice | $73.3M | 1.1K | $69.1K |
| Ambulance Service Provider | $61.4M | 70 | $877.2K |
| Nurse Practitioner | $57.3M | 2.0K | $28.0K |
| Internal Medicine | $56.6M | 574 | $98.7K |
| Ophthalmology | $54.0M | 113 | $477.4K |
| Ambulatory Surgical Center | $52.3M | 70 | $747.1K |
| Diagnostic Radiology | $32.3M | 218 | $148.1K |
| Dermatology | $29.6M | 74 | $399.8K |
| Clinical Laboratory | $29.2M | 43 | $678.9K |
| Cardiology | $28.8M | 151 | $190.5K |
| Physical Therapist in Private Practice | $26.3M | 581 | $45.3K |
| Rheumatology | $25.5M | 29 | $878.1K |
| Orthopedic Surgery | $19.9M | 176 | $112.8K |
| Medical Oncology | $17.7M | 13 | $1.4M |
| Physician Assistant | $17.0M | 391 | $43.6K |
| Emergency Medicine | $16.3M | 334 | $48.8K |
| Mass Immunizer Roster Biller | $14.9M | 386 | $38.5K |
| Optometry | $11.9M | 364 | $32.8K |
| Pathology | $11.0M | 124 | $88.7K |
| Gastroenterology | $9.9M | 87 | $113.9K |
| Urology | $9.7M | 55 | $176.9K |
| Pulmonary Disease | $9.7M | 75 | $129.0K |
| Radiation Oncology | $9.2M | 36 | $256.8K |
| Nephrology | $8.7M | 58 | $150.2K |
Last Updated: February 2026 (data through 2023, the latest CMS release)
Note: All data is from publicly available Medicare records. OpenMedicare is an independent journalism project not affiliated with CMS.